Accutar Biotech Stock

HealthTech

Looking to sell Accutar Biotech stock or options?

Founded: 2015Funding to Date: $181M

Accutar Biotech is a developer of bio-pharmaceutical technology, aimed at hastening the process of drug discovery. The company employs computational drug design, supplemented by wet-lab validation. They offer services like ligand docking with side-chain flexibility, virtual screening, and prediction of a drug's ADME properties. This facilitates researchers in significantly reducing the time and expense typically involved in traditional drug discovery processes.

Investors include:

Further Key Investors:

Hedosophia, CMS Ventures, Karista (Paris), YITU, Mirae Asset Capital, 5Y Capital, Yunfeng Capital, 3W Partners Capital, Newton BioCapital, Primavera Capital Group, CDH Investments, ZhenFund, IDG Capital.

Looking to sell Accutar Biotech Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you